Article

EHR Security at Risk

A newly released, 15-month study from the eHealth Vulnerability Reporting Program (eHVRP)--which included a survey of more that 850 provider organizations...

A newly released, 15-month study from the eHealth Vulnerability Reporting Program (eHVRP)--which included a survey of more that 850 provider organizations--shows that EHRs remain open to security breaches, partly because certification criteria don't address application hardening or known vulnerability reporting, according to Robert Mandel, MD, vice president, Health Care Services, Blue Cross Blue Shield of Massachusetts and a board member of eHVRP. “The industry is investing in, and relying heavily on, the promise that these systems offer improvements in quality and efficiency of care,” said Robert Mandel, MD, vice president, Health Care Services, Blue Cross Blue Shield of Massachusetts and a board member of eHVRP. “As such, we must take every measure possible to protect these systems, avoid any disruption in their use, and to ensure consumer confidence is maintained.”

Read more...

For those of you with an EHR system, do you feel the information within it is safe? Do these results worry you? If so, how will you act on that?

For those without an EHR system, do these study results further back up your reluctance to enter the paperless world? Post a comment! We'd love to hear what you have to say.

Related Videos
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Christopher Bunick, MD, PhD: Facts About Systemic Therapies’ Safety, Mechanism of Action
Carla Nester, MD | Credit: HCPLive
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
© 2024 MJH Life Sciences

All rights reserved.